CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Trinity Medical Group USA, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Trinity Medical Group USA, Inc.
Suite 300, 30021 Tomas Street
Phone: (949) 459-2170p:949 459-2170 Rancho Santa Margarita, CA  92688  United States Fax: (949) 459-2163f:949 459-2163
This company ceased filing statements with the SEC on 5/10/2004.
This company is no longer actively traded on any major stock exchange.
Business Summary
Trinity Medical Group USA, Inc. (Trinity USA) is a development-stage company with rights to market a Human Immunodeficiency Virust (HIV)-immunogen, REMUNE, which is a therapeutic vaccine treatment designed to induce specific T-cell responses in people infected with the Human Immunodeficiency Virus (HIV). The Company acquired the right to develop and market REMUNE in 10 Southeast Asian countries, with Thailand as the lead nation, from The Immune Response Corporation through a licensing agreement entered into on September 15, 1995.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/200212/31/2001YesYes---

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board ArunChurdboonchart 65 12/1/1999 12/1/1999
Chief Executive Officer, Director James S.Namnath 50 9/1/1998 9/1/1998
Chief Financial Officer, Executive Vice President-Finance, Treasurer Gary E.Wilson 40
4 additional Officers and Directors records available in full report.

General Information
Number of Employees: 3 (As of 12/31/2001)
Outstanding Shares: 19,518,105 (As of 12/16/2002)
Shareholders: 175
Stock Exchange: OTC
Federal Tax Id: 680438943
Fax Number: (949) 459-2163
Email Address: gwilson@trinitymg.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023